Status:
TERMINATED
A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Jaundice
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients who present with obstructive jaundice due to a malignant stricture often undergo a battery of tests for diagnosis, treatment options, and prognosis. An endoscopic retrograde cholangiopancreat...
Eligibility Criteria
Inclusion
- Subjects must be able to review and sign informed consent.
- Subjects must require biliary stenting for the relief of their symptoms as well as FNA biopsy for proper diagnosis.
- Suspected mass should be located in the head, uncinate, or neck of the pancreas.
Exclusion
- Cannot give and sign informed consent.
- The suspected mass is located in the body or tail of the pancreas.
- The patient may be a candidate for palliative biliary stenting (in which a metal stent would be placed)
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01514058
Start Date
November 1 2011
End Date
September 1 2012
Last Update
August 10 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States, 27157